"ProSense® offers the first new innovation in the treatment of women aged 70 and above with low-risk early-stage breast cancer in decades. We are proud to deliver a significant advancement and ...
State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, ...
Boehringer Ingelheim Canada announced that JASCAYD™ (nerandomilast) has received authorization from Health Canada for the treatment of adults with idiopathic pulmonary fibrosis (IPF) and adults with ...
Drugs have been the standard migraine treatment for decades. The severe headaches, nausea, and other problems associated with this common disorder now have a digital treatment option, a mobile app ...
Few readers would be surprised to read that Americans are dissatisfied with their health care coverage — an outrage that the December 2024 assassination of UnitedHealthcare CEO Brian Thompson arguably ...
Please provide your email address to receive an email when new articles are posted on . Coacillium is the first and only drug candidate for children and adolescents that have both moderate and severe ...
HB 4965 permits switching to an alternative medically appropriate treatment of equal or lesser value after initial approval, eliminating duplicative prior authorization for WV PEIA members. Prior ...
Add Yahoo as a preferred source to see more of our stories on Google. Fighting for health care claim approvals 05:19 UnitedHealthcare said on Tuesday it is eliminating "prior authorization" ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. UnitedHealthcare, the nation's largest insurer, announced it will drop prior authorization ...
CAESAREA, Israel, Oct. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted marketing authorization for ProSense®, a minimally invasive cryoablation treatment for patients ...
UnitedHealthcare said on Tuesday it is eliminating "prior authorization" requirements for 30% of medical services that previously required insurer approval, a policy shift that could eliminate red ...